Kåre Schultz
Overview
Kåre Schultz received an average of $18M in total compensation, including $2M in salary, at Teva Pharmaceutical Industries from 2017 to 2021.
2021Teva Pharmaceutical IndustriesPresident and Chief Executive Officer
2020Teva Pharmaceutical IndustriesPresident and Chief Executive Officer
2019Teva Pharmaceutical IndustriesPresident and Chief Executive Officer
2018Teva Pharmaceutical IndustriesPresident and Chief Executive Officer
2017Teva Pharmaceutical IndustriesPresident and Chief Executive Officer
Source: SEC filings on April 13, 2022, April 21, 2021, April 22, 2020, April 16, 2019, and April 25, 2018.
Related executives
We found 14 more executives who work or worked at Teva Pharmaceutical Industries.
Sven Dethlefs
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
Eli Kalif
Teva Pharmaceutical Industries
Chief Financial Officer
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
Carlo de Notaristefani
Teva Pharmaceutical Industries
Former Executive Vice President, Global Operations
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
News
Teva Pharmaceutical Industries CEO Kåre Schultz's 2021 pay slips 7% to $15M
April 13, 2022
Teva Pharmaceutical Industries CEO Kåre Schultz's 2020 pay jumps 36% to $16M
April 21, 2021
Teva Pharmaceutical Industries CEO Kåre Schultz's 2019 pay falls 64% to $12M
April 22, 2020
Teva Pharmaceutical Industries CEO Kåre Schultz's 2018 pay jumps 91% to $32M
April 16, 2019